RegisterLogin

TP-1287

CAT: 0804-HY-153260-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-153260-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
TP-1287, a prodrug of Alvocidib (HY-10005), is an orally active CDK9 inhibitor[1].
CAS Number
[2044686-42-0]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tp-1287.html
Purity
95.10
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C) |Methanol : 125 mg/mL (ultrasonic)
Smiles
O=P(O)(O)OC1=CC(O)=C(C(C=C(C2=C(C=CC=C2)Cl)O3)=O)C3=C1[C@@H]4[C@@H](CN(CC4)C)O
Molecular Formula
C21H21ClNO8P
Molecular Weight
481.82
References & Citations
[1]Tyagi E, et al. The Oral CDK9 Inhibitor, TP-1287, Is Active in Non-Clinical Models of Multiple Myeloma. Blood, 2018, 132: 3269.|[2]Kim W, et al. TP-1287, an oral prodrug of the cyclin-dependent kinase-9 inhibitor alvocidib. Cancer Research, 2017, 77 (13_Supplement) : 5133-5133.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
CDK9

Related Products

CatalogName
HY-119127TP-680
HY-114224TP-271
HY-138561EFdA-TP
HY-143518-01TP-16
HY-100517-01TP-472
HY-101857-01TP-020
HY-147316-01TP-5801
HY-157930TP-2
HY-13952-01TP-808
HY-N10168TP-1161

Alternative Products

CatalogName
BA3828-10TP-1287
MZIP1287-PA-1miRZip-1287 anti-miR-1287 microRNA construct Bacterial streak
MPH01118hsa-miR-1287 Primers
MPH02147hsa-miR-1287-3p Primers
MPH02148hsa-miR-1287-5p Primers
MIH01219hsa-miR-1287 miRNA Inhibitor
MNH01219hsa-miR-1287 miRNA Antagomir
MBS8311449-01hsa-miR-1287-5p miRNA Agomir
MBS8300141-01hsa-miR-1287-3p miRNA Mimic
MNH01220hsa-miR-1287-3p miRNA Antagomir

Popular Products